For the year ending 2025-12-31, RPID made $33,587K in revenue. -$47,123K in net income. Net profit margin of -140.30%.
| Income Statement | 2025-12-31 | 2024-12-31 | ||
|---|---|---|---|---|
| Total revenue | 33,587 | 28,051 | ||
| Cost of revenue-Product | 25,979 | - | ||
| Cost of revenue-Service | 6,561 | - | ||
| Research and development | 13,603 | 14,597 | ||
| Sales and marketing | 12,082 | 13,266 | ||
| Cost of revenue | - | 28,160 | ||
| General and administrative | 22,754 | 21,947 | ||
| Total costs and operating expenses | 80,979 | 77,970 | ||
| Loss from operations | -47,392 | -49,919 | ||
| Interest income | 1,509 | - | ||
| Interest expense | 1,090 | - | ||
| Other expense, net | -110 | -112 | ||
| Interest income, net | - | 3,164 | ||
| Total other income, net | 309 | 3,052 | ||
| Loss before income taxes | -47,083 | -46,867 | ||
| Federal | 0 | - | ||
| State | 0 | - | ||
| Foreign | 40 | - | ||
| Total current income tax expense | 40 | - | ||
| Federal | 10,034 | - | ||
| State | 1,389 | - | ||
| Foreign | 0 | - | ||
| Total deferred income tax provision | 11,423 | - | ||
| Change in deferred tax asset valuation allowance | 11,423 | - | ||
| Income tax expense | 40 | 22 | ||
| Net loss | -47,123 | -46,889 | ||
| Basic EPS | -1.05 | -1.08 | ||
| Diluted EPS | -1.05 | -1.08 | ||
| Basic Average Shares | 44,679,341 | 43,575,705 | ||
| Diluted Average Shares | 44,679,341 | 43,575,705 | ||
RAPID MICRO BIOSYSTEMS, INC. (RPID)
RAPID MICRO BIOSYSTEMS, INC. (RPID)